Over the course of the year we have been highlighting some of the 100 most read articles on the Acorn Regulatory website. Again, we are featuring another 10 of the top 100 most read articles on this website. These articles have been clicked on and read thousands of times. You can click on the headline to read the article in full or you can click here to read and see the full list of the top 100 articles on our website. EMA suggest differently. Statistical data released by the EMA has revealed that 44% of all Type I variation applications received for assessment by the EMA contain errors. It is reasonable to assume that these figures are mirrored for National and MRP variations. The figure of 44% is quite high when you consider that the variations classification guideline for Type I variations is quite detailed. The pharmaceutical industry is always pursuing initiatives to achieve “perfection” in our processes. This lean approach increases efficiency, improves quality and achieves what the Pharmaceutical industry is primarily focused on, providing safe and effective medicinal products to the public. The function of Regulatory Affairs is no different. Identifying areas of improvement and increasing “Right First Time” is a goal of all regulatory personnel. This article details the common deficiency areas with the idea of promoting awareness. Acorn Regulatory took part in the 2017 Grant Thornton 5K challenge in the Dublin Docklands. The event saw 5000 runners of all abilities take to the streets of the Dublin Docklands to run 5KM. The 5K challenge has been an annual event for the staff at Acorn Regulatory and this year we were delighted to be able to bring 2 teams to take part. Barbara Rossiter from Acorn Regulatory was the first from Acorn Regulatory to cross the finish line in just over 20 minutes. pharmaceutical packaging.